News and Media | PALTmed

JAMDA

February 26, 2016

Modifiable Risk Factors for New-Onset Slow Gait in Older Adults

Despite the growing importance of slow gait as a universal screen of health, systematic investigation of risk factors for incident slow gait is lacking. Our objective was to identify potentially modifiable risk factors for incident slow gait.

JAMDA

February 26, 2016

Advance (Meta-) Directives for Patients with Dementia who Appear Content: Learning from a Nationwide Survey

Whether health care professionals should respect a properly executed advance directive (AD) refusing life support in late-stage dementia even if the patient seems contented, is an ethically contested issue. We undertook a nationwide survey to assess this problem and to test a practical solution.

JAMDA

February 25, 2016

Curtailing Antipsychotic Use in LTC Medicine: Reducing Off-Label Antipsychotic Medication Use Among Maine Skilled Nursing Centers with the CALM Intervention

JAMDA

February 25, 2016

Antipsychotic and Other Psychotropic Medications in Special Care Dementia Units: Outcomes Using a Mini Behavior Rating Scale and Objective Medication Use Guideline

Newsroom

Modifiable Risk Factors for New-Onset Slow Gait in Older Adults

Advance (Meta-) Directives for Patients with Dementia who Appear Content: Learning from a Nationwide Survey

Opening Pandora's Box: The Reasons Why Reducing Nursing Home Transfers to Hospital are so Difficult

Operationalization of Frailty Index in Diabetic Older Patients

Teaching and Improving Transitions of Care Upon Hospital Discharge

Improving Patient Safety One Handoff at a Time

Amiodarone Use in Post-Acute and Long-Term Care Residents

An Innovative State-Level Collaboration to Impact Polypharmacy in Indiana Nursing Homes

Curtailing Antipsychotic Use in LTC Medicine: Reducing Off-Label Antipsychotic Medication Use Among Maine Skilled Nursing Centers with the CALM Intervention

Antipsychotic and Other Psychotropic Medications in Special Care Dementia Units: Outcomes Using a Mini Behavior Rating Scale and Objective Medication Use Guideline

Press Contact

Contact Us